Sentinus, LLC Actinium Pharmaceuticals, Inc. Transaction History

Sentinus, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.15 - $9.39 $130,308 - $171,132	18,225 Added 12.23%	167,275 $1.24 Million
Q1 2023 May 15, 2023	BUY	$8.51 - $14.26 $1.07 Million - $1.8 Million	126,050 Added 548.04%	149,050 $1.41 Million
Q4 2022 Feb 15, 2023	BUY	$7.05 - $14.41 $3,525 - $7,205	500 Added 2.22%	23,000 $244,000
Q3 2022 Nov 16, 2022	BUY	$4.81 - $8.48 $108,224 - $190,800	22,500 New	22,500 $166,000

8.31M

65.2K

21.7K

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $28.2M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

Get notified when there are updates to the investment portfolio of Sentinus, LLC, based on Form 13F filings with the SEC.

Stay updated on Sentinus, LLC with notifications on news.